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grams to provide patients with pain and 
symptom control and psychosocial and 
spiritual support, and to ensure that na‑
tional guidelines are adopted by all levels 
of care and that high coverage of patients is 
ensured through several options, including 
home care [4]. On March 2010 the Italian 
Republic approved a state law (38/2010) ac‑
cording to which all citizens in need should 
have free access to palliative care or pain 
therapy facilities. This law foresees the de‑
sign of a nationwide network of three types 
INTRODUCTION
Each year 10 million people are diagnosed 
with cancer, of whom 70% will die of the dis‑
ease and 60% will experience significant pain 
[1,2]. As barriers to alleviate suffering asso‑
ciated with cancer are numerous, it became 
internationally imperative to declare access 
to pain and palliative care a human right [3].
The World Health Organization (WHO) 
has recommended that all countries imple‑
ment comprehensive palliative care pro‑
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As cancer is earlier diagnosed and its treatments improve, palliative care is increasingly playing 
a vital role in the oncology population. The concept and the timing of application of palliative 
care have evolved in the last decades. The WHO pain ladder and the greater understanding of 
appropriate multimodal pain control treatments have dramatically improved the management 
of cancer pain. Integration of palliative care, which appears crucial for a proper management of 
patients, can be defined as the provision of palliative care both during curative cancer treatment 
and after curative treatment has ceased. Clinical assistance should be delivered by specialised 
physicians in different fields, psychologists and nurses, and should include all aspects of advanced-
cancer care, from diagnosis to the treatment of symptoms. A further aspect of integration of 
palliative care concerns the role of the continuity of care in acute or emergency contexts both 
for out- and inpatients. Further improvements in the management of cancer pain are needed. 
First, the WHO ladder should be modified with further steps, like those of interventional pain 
control procedures and techniques, with the aim of being effective also for the small proportion of 
nonresponsive patients. Second, more research is needed to find out which interventions aiming 
to improve continuity of care of cancer patients are beneficial to improve patient, provider 
and process of care outcomes and to identify which outcomes are the most sensitive to change. 
Of crucial importance would be the development of a standardised instrument to measure the 
continuity of care in cancer patients.
This article is a brief overview on the management of cancer pain, from the pharmacological 
treatments reported by WHO ladder, to the need for integration and continuity of care. 
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of pain therapy facilities with increasingly 
composite proficiencies from the primary 
care physician to intermediate (“spoke”) 
and high (“hub”) proficiency pain centres. 
This approach coincides with the concept 
of “stratified medicine”, which seeks to tar‑
get therapy and make the best clinical de‑
cisions for groups of similar patients [5,6]. 
Moreover, “good policies” are needed for 
an effective health care system and society. 
In this context good policies are needed to 
facilitate the implementation of palliative 
care programs in order to provide care for 
all people in need of these services, ensur‑
ing impartial access to medications and 
therapies. Thus, good policies are needed to 
provide satisfactory answers to cancer pa‑
tients’ needs, including also accessibility to 
palliative care. Palliative care should be in‑
corporated as a priority within all aspects of 
a national health plan. Accordingly, policies 
addressing essential medicines, for example, 
should include adequacy and availability of 
all palliative care medications throughout 
the country, so that they are made attainable 
wherever patients live (especially opioids for 
pain control) [7].
Care for cancer patients is provided by a 
variety of clinicians, including family phy‑
sicians, oncologists, pain and palliative care 
specialists, and many others. In order to re‑
ceive adequate access to palliative and end‑
of‑life care, continuity of care between care 
providers and care settings is essential. This is 
why more integration of palliative care into 
cancer treatment, throughout the disease 
course, is seen in major cancer centres [8].
This article provides an overview on pain 
management in cancer care, starting from 
the most adopted pharmacological treat‑
ment strategies, as reported in WHO pain 
ladder, and analysing in particular the im‑
portance of integration and continuity of 
care by health practitioners.
PALLIATIVE CARE
The concept and the timing of application 
of palliative care have evolved in the last 
decades. In 1990, the WHO defined pallia‑
tive care as «the active total care of patients 
whose disease is not responsive to curative 
treatments» [9]. Indeed, palliative care was 
initially regarded as a specialty to care for 
end‑stage and dying cancer patients. None‑
theless clinicians were conscious that «many 
aspects of palliative care are also applicable 
earlier in the course of the illness» [10]. In 
recent years, along with the longer survival 
of cancer patients and congruent progres‑
sion of their needs, the conversion, through 
treatment advances, of many cancers into 
chronic diseases, and the recognition that 
palliative treatments cannot be based on life 
expectancy, the definition and role of pallia‑
tive care has progressed. In 2012, palliative 
care has been defined as specialised medical 
care for people with serious illnesses. This 
type of care is focused on providing patients 
and families with relief from the symptoms, 
pain, stress, and to improve their quality of 
life whatever the diagnosis. Thus, palliative 
care is appropriate at any age and at any stage 
in a serious illness, and can be provided to‑
gether with curative treatment [11].
“Palliative care” includes not only pain 
and symptom management, but also psy‑
chosocial support for patients and families, 
that may be provided concurrently with can‑
cer treatment or after cancer treatment has 
ended. Palliative care, including pain therapy, 
may be (or, better, should be) provided at 
any point during the disease course, from 
diagnosis to death [12].
Successful management of cancer pain be‑
gins with an adequate and full assessment of 
the pain pathophysiology, qualitative, quan‑
titative, and temporal aspects. A compre‑
hensive knowledge of the underlying patho‑
physiology of pain is essential for effective 
management. With effective assessment 
and a systematic approach to the choice of 
analgesics, over 80% of cancer pain can be 
controlled with the use of inexpensive drugs 
that can be self‑administered by mouth at 
regular intervals. Consideration must always 
be given to treating the underlying cause of 
the pain by means of surgery, radiotherapy, 
chemotherapy, or other appropriate meas‑
ures of analgesia techniques.
Due to the high number of physicians 
who may visit a patient in as many differ‑
ent health care settings, the responsibility 
for the overall management of the patient’s 
pain may be unclear. Further fragmentation 
can occur due to lack of communication be‑
tween the hospital and the community care 
setting, a problem exacerbated by incomplete 
and inconsistent documentation of pain. In 
the region of Emilia Romagna, Italy, a pain 
diary has been developed as a follow up in‑
strument [13]. Patients self report on this 
personal diary their daily pain scores and 
therapy and ideally they may make it avail‑
able anytime they interact with health care 
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providers. Such instrument is of extreme 
importance for a fluent continuity of care, 
even when a patient is taken care of by dif‑
ferent specialists at different times and at 
different settings.
THE WHO PAIN LADDER
The WHO pain ladder [14] is a practical 
conceptual paradigm introduced almost 30 
years ago to describe guidelines for the use 
of analgesic drugs in the management of 
pain. It was originally thought to be used in 
the management of cancer pain, but is now 
widely used by professionals for the man‑
agement of pain also in non‑cancer patients. 
The WHO pain ladder implies the use of a 
limited number of relatively inexpensive 
medications in a stepwise approach. It 
helped legitimise the use of opioids for treat‑
ment of cancer pain and stimulated multiple 
educational campaigns worldwide on the 
use, benefits, and side effects of drugs in the 
treatment of pain. This paradigm is part of 5 
simple recommendations for the correct use 
of analgesics to make the prescribed treat‑
ments effective. These recommendations 
include prescription of analgesics by mouth, 
by the clock, by the ladder, for the individual 
and with attention to details. In particular, 
when possible, oral analgesics should be 
privileged; they should be given at regular 
intervals; should be prescribed according to 
pain intensity as evaluated by a scale of pain 
intensity; the dosing of analgesics should 
be tailored to the individual; and any effort 
should be made so that the patients, their 
family, and caregivers will all have the nec‑
essary information about when and how to 
administer the medications. The 1986 ver‑
sion of the WHO analgesic ladder asserts 
that treatment of pain, based on its intensity, 
should begin with a nonopioid medication. 
If the pain is still not controlled, then a weak 
opioid should be introduced; if even these 
medications are insufficient, strong opioids 
should be started. Further, nonopioid medi‑
cations can be added at each of the ladder 
steps; two analgesics of the same category 
should not be used simultaneously. The an‑
algesic ladder also includes the possibility of 
adding adjuvant treatments for neuropathic 
pain or for symptoms associated with cancer 
and with ongoing treatments. The literature 
on this approach effectiveness asserts that 
this paradigm offers inexpensive treatment 
and adequate relief for 70% to 90% of can‑
cer patients with pain [15]; however, these 
proportions have been questioned, and the 




The WHO pain ladder and the greater 
understanding of appropriate multimodal 
pain control treatments have dramatically 
improved the management of cancer pain. 
However, while the WHO method is effec‑
tive in most patients, a consistent proportion 
do not have their pain controlled adequately, 
even with optimised systemic therapy: some 
pains, like bone, neuropathic and visceral 
pain, are resistant to opioid treatments. This 
has led to the suggestion that the WHO 
ladder should be modified with a fourth (or 
fifth) step, that of interventional procedures 
and techniques [18‑21].
The specialty of pain medicine evolved 
to increased experience and skills in phar‑
macological management of pain and in 
implant and infusion techniques. The UK 
NICE guidance on supportive and pallia‑
tive care in cancer advocates that each local 
palliative care multidisciplinary team should 
have access to pain specialists with expertise 
in nerve blocking and neuro-modulation 
techniques [18].
There is a wide range of potential inter‑
ventional procedures, including:
 y Neuraxial delivery of analgesic drugs, and 
destruction of spinal and radicular nerve 
pathways.
 y Interruption of pain pathways travelling 
via the sympathetic nervous system, local 
anaesthetic and destructive techniques 
directed to peripheral nerves.
 y Other procedures, including minimally 
invasive treatments directed at bony me‑
tastases and other pain sources.
Among these, there are those known as 
neuro‑ablation techniques and those known 
as neuro‑modulation techniques, which may 
be further subdivided in electrical and phar‑
macological.
In patients with pain that is controlled by 
opioids but who experience intolerable side 
effects during systemic administration, an 
epidural or intrathecal administration may 
be more tolerable, as smaller doses of opi‑
oid are required to get the same analgesic 
effect [11,18,20,22,23]. These methods are 
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typically performed in high proficiency pain 
centres and hospitals.
Nevertheless, interventional techniques 
remain an important and frequently under‑
used part of the multimodal management 
of cancer pain. The indications for admin‑
istration of strong opioids by intrathecal 
or epidural routes remain controversial. It 
has been suggested that 8‑11% of carefully 
selected cancer patients could benefit from 
interventional procedures [10,18,22].
CONTINUITY OF CARE
Continuity is the extent to which a chain 
of distinct care interventions is experienced 
as coherent, connected, and consistent with 
the patient’s medical needs and personal 
context; it encompasses two main elements: 
long‑term and patient‑centred care [24]. 
There are three types of care continuity:
 y Informational, where individual informa‑
tion on past events and personal status are 
used to make care appropriate.
 y Management, where an appropriate ap‑
proach is tailored to the patient’s chang‑
ing needs.
 y Relational, where a persistent curative 
association is held between a patient and 
his/her providers.
Type and setting of care influence the op‑
erating type of continuity [24].
For the cancer patient, continuity of care 
means continuity between treatments (can‑
cer and palliative care) or between different 
care providers. Care shift may occur at any 
point along the disease course. It is coordi‑
nated fluent transition between primary care 
providers and oncologists or between care in 
a cancer centres and home care, community 
or hospital. Thus, the use of care coordina‑
tion mechanisms and expert support is re‑
quired. The literature indicates that family 
physicians and community‑based care pro‑
viders are willing to provide palliative care 
if they are adequately supported by expert 
advice and enabled to increase their skills 
and confidence in providing such care. Such 
integration may result successful if pallia-
tive care is integrated immediately after 
the disease is diagnosed and if the pallia‑
tive care services occupy a significant place 
in the cancer centre [8].
Palliative care is necessarily multidisci‑
plinary. It is unlikely to expect single clini‑
cian to have the expertise to formulate the 
necessary assessment, perform the neces‑
sary interventions, and to deliver constant 
monitoring [25]. From the practical point of 
view “collaborative care” might be a better 
way to describe the fluent transition of care. 
Combination of palliative care and cancer 
treatment is the synchronised involvement 
of palliative and curative care throughout 
the disease course. Synchronisation and 
communication between palliative care and 
cancer treatment clinicians and programs 
are imperative. Such approach is often seen 
within a cancer treatment centre; however, 
as care is often also provided in hospital set‑
tings both for acute crisis and on outpatient 
consultation basis [8],  synchronisation and 
communication are needed there as well.
CONTINUITY OF CARE AND 
INTEGRATION OF CARE
In cancer palliative care, continuity of care 
is the transition of the responsibility for care 
from the curative cancer treatment providers 
to a palliative care provider (a primary care 
physician, a home care team, or a hospice 
team) [26]. Integration of palliative care into 
curative cancer treatment can be defined as 
the provision of palliative care both during 
curative cancer treatment and after curative 
treatment has ceased. Integration is often 
an indicator that continuity of care will 
also occur. It has been reported that care 
is improved by introducing palliative care 
upstream through integration in existing 
clinical care settings [27].
Palliative care may be introduced down-
stream or upstream. In terms of continuity 
of care, best practices refers to those that 
introduce palliative care upstream during 
cancer treatment (as opposed to down-
stream, where palliative care is provided 
mainly at the end‑of‑life stage of the disease) 
and that involve the primary care physician. 
Introducing palliative care downstream un‑
dermines the fluent continuity of care. The 
best provision of continuity of care is by pri‑
mary care physicians and community‑based 
care when adequate home and community 
care is provided and is linked to hospitals 
and treatment centres. In some cases, cancer 
centres provide their own home or continu‑
ing care service.
It is crucial to underline that while facili‑
ties and availability of home and commu‑
nity care may favour the continuity of care, 
adequate, honest and open communication 
with patients and families are evenly essen‑
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tial [28]. During each step of the disease, 
clinicians have to provide individualised 
patient‑centred communications to outline 
treatment options in a shared decision‑mak‑
ing process which may guarantee a tailored 
continuity of care. In this way, the transition 
from curative cancer treatment to palliative 
care can occur in a shared, awarded and non‑
traumatic way [29].
The literature on integration of palliative 
care and curative cancer treatment gener‑
ally describes programs developed within 
tertiary care hospitals and cancer treatment 
centres or in close association with them.
Integration of palliative and curative care 
is a growing trend that facilitates access to 
palliative care upstream, rather than down-
stream, allows better pain and symptoms 
control, psychosocial support, public health 
benefits, and quality of life [1,2,4]. Inte‑
grated programs in cancer centres typically 
include clinical and psychosocial inpatient 
services (often a palliative care unit), day or 
outpatient clinics, link to community‑based 
end‑of‑life care services such as hospice, 
education and research [2,27,30]. Among 
others, one example may be the National 
Cancer Institute in Milan, Italy (www.is‑
titutotumori.mi.it). This institute provides 
research, palliative care, pain therapy, and 
rehabilitation programs for both in‑ and 
outpatients [8,31]. Another example is the 
ANT Italia Onlus Foundation in Bologna, 
Italy (http://www.ant.it). The latter is a non‑
profit Foundation which guarantees social 
and clinical assistance to cancer patients and 
their families in 9 regions of Italy. Clinical 
assistance, delivered by specialised physi‑
cians, psychologists, and nurses, includes all 
aspects of advanced‑cancer patient home‑
care from diagnosis to the treatment of 
symptoms. This foundation has strong re‑
search and clinical collaboration link with 
the Bologna University‑Teaching‑Hospital 
pain centre, Italy [32].
THE HOSPITAL SETTING
A further aspect of integration of palliative 
care into other medical milieu concerns the 
role of palliative care in acute or emergency 
contexts both for out‑ and inpatients. Many 
cancer patients will be admitted to hospital 
during the disease or late in life and die in 
acute care. They may be undergoing curative 
treatment or not, and they might have been 
at home but unable to remain there for a 
variety of reasons. The hospital may become 
a crucial point in the continuity and inte‑
gration of palliative care both in the acute 
settings and as support to palliation in par‑
ticularly difficult cases. Pain management is 
one of the pillars of palliative care integration 
in the hospital. In a cross‑sectional survey 
conducted in a teaching hospital to gather 
benchmark data regarding pain prevalence 
and predictors among the entire inpatient 
population, moderate to severe pain was 
reported by 25% of the patients [33]. In‑
terestingly high pain prevalence was found 
in the Cancer‑Radiotherapy ward (63.3%) 
while lower, yet significant, pain prevalence 
was found in the Oncology ward (32.3%). 
In this study, protracted hospitalisation and 
prolonged pain duration were associated with 
major pain severity, while predictor analysis 
suggested that attention should be paid to 
pain management in young adults, socially 
vulnerable patients and those with protracted 
hospitalisation and pain, like cancer patients.
Hospital pain clinics are now made avail‑
able all over Italy. They deliver pain manage‑
ment both for inpatients and outpatients. 
Among the main elements that a tertiary‑
teaching‑hospital pain clinic may offer to 
the palliative care network are:
 y Pain management follow‑up for outpa‑
tients and inpatients.
 y Pain management consultation and expert 
support to primary care physicians and to 
community or home‑care cancer facilities.
 y Interventional procedures and techniques 
in pain management.
 y Innovative pain management trials.
 y Pain management research and education.
COMMUNICATION AND 
PSYCHOLOGICAL FACTORS
Continuity of care is achieved by bridging 
single care interventions in the care pathway 
as well as by supporting aspects such as pa‑
tients’ values and patient beliefs, sustained re‑
lationships, and care plans. For most patients, 
physical pain is only one of the symptoms 
experienced during the disease. Relief of pain 
should therefore be seen as part of a compre‑
hensive pattern of care which may include 
the physical, psychological, social, and spir‑
itual aspects of suffering. These components 
should be addressed simultaneously. In many 
cases of resistant pain, psychological factors 
play a central role in the experience of pain. 
Although emotional aspects don’t cause pain 
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directly, they contribute to a person’s per‑
ception of pain and its effects, and they can 
influence the response to pain and treatment 
[34]. In order to improve the quality of life 
of these patients, literature suggests to asso‑
ciate cognitive‑behavioural interventions to 
pharmacological pain treatment. These psy-
choeducational interventions are usually 
utilised to treat symptom clusters, like pain, 
fatigue and sleep disturbance [35].
For continuity to exist, care must be expe‑
rienced as persistent and linked. The expe‑
rience of continuity may differ for patients 
and providers. Among patients and their 
families, the perception of continuity is 
achieved when providers are aware of past 
medical events, different providers concur 
with the care plan, and the acquainted car‑
egiver will provide care also in the future. 
For providers, the perception of continuity 
is achieved when they have adequate infor‑
mation regarding the patient to best apply 
their expertise and the assurance that their 
professional decisions will be accepted by 
other providers. While continuity may vary 
in different care contexts, continuity can 
contribute to ameliorate quality of care.
An efficient communication to patients 
and families should consider their very own 
concept of continuity of care by understand‑
ing the patient’s current beliefs, his/her 
needs for information and role preferences 
in decision‑making involvement. Individu‑
alised approach instead of a “one‑size‑fits‑
all approach” to communication grants the 
quality of clinicians‑patient communica‑
tion [36].
CONCLUSIONS AND FINAL 
CONSIDERATIONS
The essential components of palliative 
care are effective control of symptoms and 
effective communication with patients, their 
families, and whoever is involved in their 
care process.
While opioids are the main stem of can‑
cer pain therapy, some pains are resistant to 
opioid treatments. Adjuvant drugs, radio‑
therapy, and anaesthetic block techniques 
may be considered in such cases.
As the disease progresses, continuity of 
care becomes more and more important: co‑
ordination between care providers is impera‑
tive, and information must flow punctually 
and efficiently between professionals in all 
care contexts and also towards patients and 
their caregivers.
More research is needed to find out which 
interventions aiming to improve continuity 
of care in the follow‑up of cancer patients 
are the most beneficial to improve patient, 
provider and process of care outcomes and 
to identify which outcomes are the most 
sensitive to change and the most meaning‑
ful regarding continuity of care. Of crucial 
importance would be the development of 
a standardised instrument to measure the 
continuity of care in cancer patients.
Key points
 y In Italy, free access to pain management in cancer and non-cancer patients is now con-
sidered a human right
 y Palliative care is based on the stepwise approach reported in the WHO pain ladder; after 
the last step, a further step could be included in the ladder for those whose pain is resistant 
even to strong opioids: interventional procedures and techniques
 y Pain management should be introduced upstream during cancer treatment, at the time of 
diagnosis, instead of being provided just at the end-of-life stage
 y Continuity of care among health care professionals, wards and hospitals and communica-
tion with patients and their caregivers are pillars of a correct management of cancer pain
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